What is the current Price Target for the Candel Therapeutics Inc stock?

The average Candel Therapeutics Inc target price is $22.95. This is 98.70% higher than the current stock price. The highest price target is 163.64%, the lowest is 4.94%. 10 Analysts have issued a price target Candel Therapeutics Inc 2027 .

How high will the Candel Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Candel Therapeutics Inc stock will rise. The performance of stocks, including the Candel Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Candel Therapeutics Inc stock today?

The performance of Candel Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Candel Therapeutics Inc stock fall?

The decline in Candel Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Candel Therapeutics Inc Forecast, price target & analysts

$11.55

2.30%

Nasdaq, Sep 24, 04:27 pm EDT. Closed.

ISIN

US1374041093

Symbol

CADL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Candel Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Candel Therapeutics Inc Classifications & Recommendation

Buy

87%

Hold

13%

Candel Therapeutics Inc Price Target

Target Price	$22.95
Price	$11.55
Potential	98.70% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target Candel Therapeutics Inc 2027 . The average Candel Therapeutics Inc target price is $22.95. This is 98.70% register free of charge higher than the current stock price. The highest price target is $30.45 163.64% register free of charge , the lowest is $12.12 4.94% register free of charge .
	A rating was issued by 15 analysts: 13 Analysts recommend Candel Therapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Candel Therapeutics Inc stock has an average upside potential 2027 of 98.70% register free of charge . Most analysts recommend the Candel Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

11 Analysts have issued a Candel Therapeutics Inc forecast for earnings per share. The average Candel Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-1.07 24.65% unlock
2028	$0.12 111.21% unlock

Current	-9.49	17.16%
2026	-7.96 16.10% unlock
2027	-10.52 32.16% unlock
2028	94.74 1,000.57% unlock

Candel Therapeutics Inc...

Current Candel Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
B of A Securities	Locked ➜ Locked	Locked	Sep 21 2026
B of A Securities	Locked ➜ Locked	Locked	Aug 14 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 13 2026
Stifel	Locked ➜ Locked	Locked	Jul 13 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Apr 20 2026
Citigroup	Locked ➜ Locked	Locked	Mar 18 2026
Citigroup	Locked ➜ Locked	Locked	Mar 13 2026

Analyst Rating	Date
Locked B of A Securities: Locked ➜ Locked	Sep 21 2026
Locked B of A Securities: Locked ➜ Locked	Aug 14 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 13 2026
Locked Stifel: Locked ➜ Locked	Jul 13 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Apr 20 2026
Locked Citigroup: Locked ➜ Locked	Mar 18 2026
Locked Citigroup: Locked ➜ Locked	Mar 13 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now